Aktis Oncology, Inc.
$16.85+$0.03 (+0.18%)
Aktis Oncology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.72% below the high.
NASDAQ · WRNT · USD
Stock price
Quote as of Aug 6, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Warrantee Inc. American Depositary Shares’s quoted price sits in the lower half of its reported 52-week range, 62.98% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Warrantee Inc. operates as a technology firm specializing in marketing and market research, providing corporate sponsors with highly targeted campaign solutions. The company engages customers by offering participation in marketing initiatives that include perks such as extended warranties on durable products or various health benefits. Its clientele in Japan comprises manufacturers and distributors of home appliances and healthcare equipment, as well as health food distributors. Established in 2013, Warrantee Inc. maintains its headquarters in Osaka.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:25 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$16.85+$0.03 (+0.18%)
Aktis Oncology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.72% below the high.
$1.74$0.00 (0.0%)
Bonso Electronics International Inc.’s quoted price sits in the lower half of its reported 52-week range, 32.3% below the high.
$1.11-$0.27 (-19.57%)
Edgio, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.36% below the high.
$0.15$0.00 (0.0%)
LeddarTech Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.45% below the high.
$0.06+$0.02 (+36.18%)
VIQ Solutions Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.01% below the high.
$0.08$0.00 (0.0%)
Borqs Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 61.0% below the high.
$0.65+$0.02 (+2.94%)
Flyte Aviation, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.89% below the high.
$6.83-$0.26 (-3.67%)
UTime Limited’s quoted price sits in the lower half of its reported 52-week range, 97.64% below the high.